oCular Examination at Cell RESolution With Optical TransmissionTomography
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts
About this trial
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.
Eligibility criteria
Qualifiers
200 subjects aged 18 to 80 years;
Male or female;
with an ocular disease affecting the cornea, ocular surface, lens (cataract) or glaucoma, or requiring refractive surgery or post-refractive surgery follow-up;
Are covered by the French Assurance Maladie;
Disqualifiers
Inability to hold a still position on a standard ophthalmic chin rest;
Conjunctivitis or other contagious contact disease in active phase;
Having an implanted pacemaker or other electronic medical device;
Having a predisposition to iridocorneal angle closure;
Trial design
Treatments tested in this trial
- Optical Transmission Tomography (OTT)
- Optical Coherence Tomography (OCT)
- Specular Microscopy (SM)
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov